Article abstract


Nature Genetics 41, 677 - 687 (2009)
Published online: 10 May 2009 | Corrected online: 17 May 2009 | doi:10.1038/ng.384

Genome-wide association study of blood pressure and hypertension

Daniel Levy1,2,29, Georg B Ehret3,4,29, Kenneth Rice5,29, Germaine C Verwoert6,7,28,29, Lenore J Launer8,29, Abbas Dehghan6, Nicole L Glazer9, Alanna C Morrison10, Andrew D Johnson1,2, Thor Aspelund11,12, Yurii Aulchenko6, Thomas Lumley5, Anna Köttgen13, Ramachandran S Vasan1,14,15,16,17, Fernando Rivadeneira6,7, Gudny Eiriksdottir11, Xiuqing Guo18, Dan E Arking3, Gary F Mitchell19, Francesco U S Mattace-Raso6,20, Albert V Smith11, Kent Taylor18, Robert B Scharpf21, Shih-Jen Hwang1,2, Eric J G Sijbrands7, Joshua Bis9, Tamara B Harris8, Santhi K Ganesh3,22, Christopher J O'Donnell1,2, Albert Hofman6, Jerome I Rotter18, Josef Coresh13, Emelia J Benjamin1,14,15,16,17, André G Uitterlinden6,7, Gerardo Heiss23, Caroline S Fox1,2, Jacqueline C M Witteman6,28, Eric Boerwinkle10, Thomas J Wang1,24, Vilmundur Gudnason11,12,29, Martin G Larson1,25,29, Aravinda Chakravarti3,13,29, Bruce M Psaty26,27,29 & Cornelia M van Duijn6,29


Blood pressure is a major cardiovascular disease risk factor. To date, few variants associated with interindividual blood pressure variation have been identified and replicated. Here we report results of a genome-wide association study of systolic (SBP) and diastolic (DBP) blood pressure and hypertension in the CHARGE Consortium (n = 29,136), identifying 13 SNPs for SBP, 20 for DBP and 10 for hypertension at P < 4 times 10-7. The top ten loci for SBP and DBP were incorporated into a risk score; mean BP and prevalence of hypertension increased in relation to the number of risk alleles carried. When ten CHARGE SNPs for each trait were included in a joint meta-analysis with the Global BPgen Consortium (n = 34,433), four CHARGE loci attained genome-wide significance (P < 5 times 10-8) for SBP (ATP2B1, CYP17A1, PLEKHA7, SH2B3), six for DBP (ATP2B1, CACNB2, CSK-ULK3, SH2B3, TBX3-TBX5, ULK4) and one for hypertension (ATP2B1). Identifying genes associated with blood pressure advances our understanding of blood pressure regulation and highlights potential drug targets for the prevention or treatment of hypertension.

Top
  1. National Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham, Massachusetts, USA.
  2. Center for Population Studies, NHLBI, Bethesda, Maryland, USA.
  3. McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
  4. Division of Cardiology, Geneva University Hospital, Geneva, Switzerland.
  5. Department of Biostatistics, University of Washington, Seattle, Washington, USA.
  6. Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands.
  7. Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.
  8. National Institute of Aging's Laboratory for Epidemiology, Demography, and Biometry, Bethesda, Maryland, USA.
  9. Cardiovascular Health Research Unit and Department of Medicine, University of Washington, Seattle, Washington, USA.
  10. Human Genetics Center, University of Texas Health Science Center, Houston, Texas, USA.
  11. Icelandic Heart Association, Kopavogur, Iceland.
  12. University of Iceland, Reykjavik, Iceland.
  13. Department of Epidemiology and Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
  14. Department of Cardiology, Boston University School of Medicine, Boston, Massachusetts, USA.
  15. Department of Preventive Medicine, Boston University School of Medicine, Boston, Massachusetts, USA.
  16. Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, Massachusetts, USA.
  17. Epidemiology Section, Boston University School of Public Health, Boston, Massachusetts, USA.
  18. Medical Genetics Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.
  19. Cardiovascular Engineering, Inc., Norwood, Massachusetts, USA.
  20. Department of Internal Medicine, Section of Geriatric Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.
  21. Department of Biostatistics, Johns Hopkins University, Baltimore, Maryland, USA.
  22. National Human Genome Research Institute, Vascular Biology Section, Bethesda, Maryland, USA.
  23. Carolina Cardiovascular Biology Center, Chapel Hill, North Carolina, USA.
  24. Division of Cardiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  25. Department of Mathematics and Statistics, Boston University, Boston, Massachusetts, USA.
  26. Departments of Epidemiology, Medicine, and Health Services, University of Washington, Seattle, Washington, USA.
  27. Center for Health Studies, Group Health, Seattle, Washington, USA.
  28. Member of the Netherlands Consortium on Healthy Aging (NCHA), The Netherlands.
  29. These authors contributed equally to this work.

Correspondence to: Daniel Levy1,2,29 e-mail: levyd@nhlbi.nih.gov

Correspondence to: Cornelia M van Duijn6,29 e-mail: c.vanduijn@erasmusmc.nl

* NOTE: In the version of this article initially published online, the respective exponents of the P values for association of rs8096897 and rs880315 with SBP were transposed. The error has been corrected for the print, PDF and HTML versions of this article.


Extra navigation

Subscribe to Nature Genetics

Subscribe

Open Innovation Challenges

naturejobs

ADVERTISEMENT